Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06456112
Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV
Sponsor: Anhui Provincial Hospital
View on ClinicalTrials.gov
Summary
Systematic evaluation of the value of molecular residual lesions of cervical cancer based on circulating tumor HPV in the prognostic evaluation and recurrence monitoring of cervical cancer patients.
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
83
Start Date
2024-07-01
Completion Date
2026-07-30
Last Updated
2024-07-01
Healthy Volunteers
No
Conditions
Locations (1)
Anhui Provincal Hospital
Hefei, Anhui, China